An interactive learning activity that teaches learners how to complete risk assessment and develop a guideline driven treatment plan to optimize therapy for ASCVD patients. Through the use of case studies, learners will challenge their knowledge and reinforce key concepts in secondary prevention.

Learning Objectives
Upon completion of this activity, participants should be able to:

1. Identify very high-risk ASCVD patients according to the 2018 cholesterol guidelines.
2. Identify intensity of low-density lipoprotein cholesterol (LDL-C)-lowering therapy for patients with ASCVD at very high risk and not at very high risk.
3. Recognize the importance of matching the intensity of therapy to patient’s absolute risk of recurrent ASCVD events.

Target Audience
The intended audience is cardiovascular team clinicians who complete risk assessments and coordinate treatment plans and/or deliver care for patients with hypercholesterolemia.

Faculty
Pamela B. Morris, MD, FACC,
Professor of Medicine, Cardiology
Director, Seinsheimer Cardiovascular Health Program
Medical University of South Carolina

Peer Reviewers
Kim K. Birtcher, PharmD, MS, AACC, FNLA
Clinical Professor
University of Houston College of Pharmacy

Salim S. Virani, MD, PhD, FACC
Professor, Baylor College of Medicine
Section of Cardiovascular Research
Director, Cardiology Fellowship Training Program
Cardiologist, Michael E. DeBakey Veterans Affairs Medical Center

Acknowledgments
Educational grant support provided by REGENERON

Disclaimer: This activity does not offer credit.